Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Hooker Electrochemical

(Site Profile/Docket Number 193)

Location: Niagara Falls, New York

Also Known As: Hooker Chemical Co., Occidental Chemical Corp., Occidental Chemical Corp., Specialty Chemical Div., Hooker Chemical and Plastics Corp.

Special Exposure Cohort Petition Information

The Special Exposure Cohort (SEC) is a unique category of employees established by The Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 "specified cancers," and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.

Open/Active SEC Petitions

To date, there are no open/active SEC petitions from Hooker Electrochemical.

Classes Not Added to the SEC

  • All employees who worked in any location at the Hooker Electrochemical Corporation during the operational period from January 1, 1943 through December 31, 1948, and during the residual period from January 1, 1949 to December 31, 1976.

    Note: Please see Petition 141 below.

Petitions Qualified for Evaluation

Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.

Petitions

Petition 141Aug 14, 1942 to Nov 30, 1949

Petition 141
Steps in Petition Process: Petition Details:

Date Received

March 6, 2009

Date Qualified for Evaluation

October 16, 2009

Summary of Information in Petition

Job Titles and/or Job Duties: All employees who worked in any location

Period of Employment: January 1, 1943 to December 31, 1948, and from January 1, 1949 to December 31, 1976

Copy of the Petition Received

May 3, 2010 [570 KB (9 pages)]

Federal Register Notice Announcing that a Hooker Electrochemical SEC Petition has met the Minimum Qualifications for Review and Evaluation

October 30, 2009 [40 KB (1 page)]

SEC Petition Evaluation Report

May 3, 2010 [274 KB (51 pages)]

Evaluation Report Sent to the Advisory Board

May 4, 2010

Petition Discussed by the Advisory Board

The Advisory Board discussed the petition on May 19, 2010, and August 24, 2011, during its regular meetings.

Advisory Board Recommendation on SEC Petition

December 29, 2011 [24 KB (2 pages)]

HHS Letters to Congress Regarding the SEC Petition

February 2, 2012 [57 KB (9 pages)]

HHS Determination Concerning a Petition to Add Members to the Special Exposure Cohort

Determination

Federal Register Notice: Determination Regarding a Class of Employees for Addition to the Special Exposure Cohort

Determination

Note: A "designation" will be published if there is a recommendation to add a class to the SEC. A "determination" will be published if there is a recommendation not to add a class to the SEC.

Effective Date for the SEC Class

Not applicable at this time.

Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort

Not applicable at this time.

Letter to DOL Regarding the Addition of a New Class of Employees to the SEC

Not applicable at this time.

Advisory Board Work Group on Uranium Refining Atomic Weapons Employers (AWEs)

(This Work Group was formerly known as the Advisory Board's Work Group on TBD 6001)

This Work Group is responsible for the review of TBDs and SEC petitions for uranium refining AWEs as assigned to it by the Board. It will also review any reports developed by the Board's contractor (SC&A) pertaining to these TBDs and SEC petitions, and will assist NIOSH and SC&A in resolving issues that arise through the review process. The Work Group will make recommendations to the Board regarding such SEC petitions. Sites currently being considered by the Work Group include Baker-Perkins Co., Du Pont Deepwater Works, Electro Metallurgical, Hooker Electrochemical, and United Nuclear Corp.

Work Group Members:

  • Henry A. Anderson, M.D. (Chair)
  • R. William Field, Ph.D., M.S.
  • David Kotelchuck, PhD, MPH

Meeting Info:

Technical Documents

If the energy employee's personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.

Technical Basis Documents

Advisory Board and NIOSH Discussions on Hooker Electrochemical

The Hooker Electrochemical discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.

The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.

Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)

NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.

  • DCAS-PER-038 Rev-0: Program Evaluation Report: Hooker Electrochemical TBD Revisions [177 KB (5 pages)]

    July 24, 2012

    About this Document: site specific appendix to Battelle-TBD-6001 (Appendix AA) was issued 6/15/2007. This was superseded by a stand-alone Technical Basis Document (TBD) on 4/4/2011 (DCAS-TKBS-0009 rev. 0). On 6/16/2011, revision 1 was issued to that document to correct an error. The changes made in revision 1 of the TBD caused external doses to operators to decrease during the operational period. No increase in any doses occurred in revision 1. Revision 0 however, did result in some increased dose when compared to Appendix AA. Therefore, Appendix AA is compared to Revision 1 in this PER in order to itemize the increased dose.

    Summary: As a result of this review, the revisions to the Hooker Electrochemical TBD did not result in the probability of causation of any previously completed claims rising to greater than 50%. A listing of those claims evaluated and their final disposition will be forwarded to the Department of Labor.

Public Comments on Hooker Electrochemical Documents

How to Submit Comments

Comments on Hooker Electrochemical Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:

NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226

Please include the Site Profile/Docket Number (193) on all comments.

Comments Received

Document Archive for Hooker Electrochemical

 
Contact DCAS:
Contact Us:
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO